A Nanofluorescent Probe for Evaluating the Fluctuation of Aminopeptidase N in Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis
Analytical Chemistry · 10.09.2024 · 96 (36) · 14639-14649
DOI: 10.1021/acs.analchem.4c03298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 29.08.2024. Verfasst von Xiao Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Binzhou Medical University, Yantai 264003, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, CD13 Antigens, Fluorescent Dyes, Liver Cirrhosis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Research Initiation Fund of Binzhou Medical University, Taishan Scholar Project Special Funding.
Abstract (Originalsprache)
Aminopeptidase N (APN/CD13) is a widely expressed transmembrane ectoenzyme that is crucial for maintaining normal physiological activities. It exhibits abnormal activity closely associated with hepatic fibrosis and nonalcoholic fatty liver disease (NAFLD). Therefore, there is a high demand for noninvasive detection of aminopeptidase N (APN) in the diagnosis and research of related diseases. Here, we developed a small molecule fluorescent probe, Hcy-APN, which is a fluorescent probe with high sensitivity and selectivity for the detection of APN. Furthermore, we synthesized the fluorescent nanoprobe Hcy-APN@MSN by self-assembling Hcy-APN and mesoporous silica nanoparticles in solution using a combination of molecular probe design and nanofunctionalization strategies. The detection limit of this probe was 1.5 ng/mL. Hcy-APN@MSN exhibits more stable spectral characteristics compared to Hcy-APN and is suitable for detecting APN activity in live cells and mice. Hcy-APN@MSN was utilized for in vivo and intracellular imaging of NAFLD and hepatic fibrosis at different stages, as well as for a systematic assessment of APN levels in the liver. The results confirm an elevation in the expression levels of APN in NAFLD and hepatic fibrosis models. Furthermore, we investigated the inhibitory effect of the APN inhibitor bestatin in nonalcoholic fatty liver and hepatic fibrosis disease models, confirming its regulatory effect on APN levels in cells and in vivo in both disease models. Therefore, this study may offer diagnostic possibilities for detecting NAFLD and hepatic fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Binzhou Medical University, Yantai 264003, China.
- CAS Key Laboratory of Coastal Environmental Processes and Ecological Remediation, Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai 264003, China.
- College of Chemistry, Chemical Engineering and Materials Science, Shandong Normal University, Jinan 250014, China.
- College of Chemistry and Chemical Engineering, Shaoxing University, Shaoxing 312000, China.
ORCID-Profile: Lingxin Chen, Yan Huang
Förderung
- National Natural Science Foundation of China
- Research Initiation Fund of Binzhou Medical University
- Taishan Scholar Project Special Funding
Zitieren
APA
Sun, X., Wang, X., Fu, L., Wang, X., Chen, L., & Huang, Y. (2024). A Nanofluorescent Probe for Evaluating the Fluctuation of Aminopeptidase N in Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis. Analytical Chemistry, 96(36), 14639-14649. https://doi.org/10.1021/acs.analchem.4c03298
Vancouver
Sun X, Wang X, Fu L, Wang X, Chen L, Huang Y. A Nanofluorescent Probe for Evaluating the Fluctuation of Aminopeptidase N in Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis. Analytical Chemistry. 2024;96(36):14639-14649. doi:10.1021/acs.analchem.4c03298
BibTeX
@article{Sun2024,
author = {Sun, Xiao and Wang, Xinlei and Fu, Lili and Wang, Xiaoyan and Chen, Lingxin and Huang, Yan},
title = {A Nanofluorescent Probe for Evaluating the Fluctuation of Aminopeptidase N in Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis},
journal = {Analytical Chemistry},
year = {2024},
volume = {96},
number = {36},
pages = {14639--14649},
doi = {10.1021/acs.analchem.4c03298}
}
EUVIMED